PubRank

A Ashkenazi

Author PubWeight™ 144.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997 6.82
2 Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996 6.22
3 Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J Virol 1992 4.08
4 Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 2003 3.66
5 Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 2000 3.45
6 Primary structure and biochemical properties of an M2 muscarinic receptor. Science 1987 3.16
7 Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998 2.98
8 Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat Immunol 2000 2.78
9 Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med 2001 2.66
10 New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 2010 2.56
11 Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell 1999 2.42
12 Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 2001 2.40
13 Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J 1987 2.39
14 Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem 1997 2.33
15 A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol 1997 2.31
16 Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol 2000 2.29
17 Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature 1988 2.03
18 TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat Immunol 2001 1.92
19 Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science 1995 1.90
20 The MHC-binding and gp120-binding functions of CD4 are separable. Science 1989 1.77
21 Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr Biol 1996 1.72
22 Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr Biol 1999 1.63
23 Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5. Cell Death Differ 2008 1.61
24 Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res 2001 1.58
25 Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene 2007 1.57
26 A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol 1998 1.53
27 Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4. J Immunol 2001 1.46
28 The syndrome of neonatal copper deficiency. Pediatrics 1973 1.45
29 A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastro-enterology and Nutrition (ESPGAN). Eur J Pediatr 1993 1.45
30 Functional characterization of the Bcl-2 gene family in the zebrafish. Cell Death Differ 2006 1.43
31 A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry 2000 1.34
32 Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol 1998 1.34
33 Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun 1999 1.33
34 Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr Biol 1996 1.33
35 APO2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett 1998 1.32
36 Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol Cell Biol 1996 1.32
37 A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors. Nature 1992 1.26
38 Cloning and expression of a human CDC42 GTPase-activating protein reveals a functional SH3-binding domain. J Biol Chem 1993 1.20
39 Iron treatment in children with attention deficit hyperactivity disorder. A preliminary report. Neuropsychobiology 1997 1.14
40 Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Clin Cancer Res 2001 1.10
41 Delineation of the cell-extrinsic apoptosis pathway in the zebrafish. Cell Death Differ 2006 1.09
42 Histocompatibility determinants in Israeli Jewish patients with coeliac disease: population and family study. Tissue Antigens 1981 1.08
43 Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages. Scand J Immunol 2000 1.07
44 Characterization of the human 5-hydroxytryptamine1B receptor. J Biol Chem 1992 1.06
45 Comparison of dynamic (brush) and static (pressure) mechanical allodynia in migraine. Cephalalgia 2006 1.04
46 Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments. Biochemistry 1990 1.02
47 Coeliac activity of the gliadin peptides CT-1 and CT-2. Z Lebensm Unters Forsch 1986 1.00
48 Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. Proc Natl Acad Sci U S A 1995 0.99
49 Immunological assay for the diagnosis of coeliac disease: interaction between purified gluten fractions. Pediatr Res 1980 0.96
50 Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D. J Immunol 1999 0.95
51 Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity. Cytokine 1999 0.95
52 A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 1998 0.95
53 Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081. J Immunol 1996 0.94
54 Niemann-Pick disease and giant cell transformation of the liver. Acta Paediatr Scand 1971 0.94
55 Identification of cysteine-rich domains of the type 1 tumor necrosis factor receptor involved in ligand binding. J Biol Chem 1992 0.93
56 Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor. Biochemistry 1993 0.93
57 Immunoadhesins: principles and applications. Trends Biotechnol 1996 0.93
58 Celiac disease among Ashkenazi Jews from Israel. A study of the HLA class II alleles and their associations with disease susceptibility. Hum Immunol 1993 0.93
59 An in-vitro immunological assay for diagnosis of coeliac disease. Lancet 1978 0.92
60 Nocturnal acute laryngospasm in children: a possible epileptic phenomenon. J Child Neurol 2000 0.92
61 Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats. J Clin Invest 1995 0.91
62 Amino-acid sequence of the coeliac active gliadin peptide B 3142. Z Lebensm Unters Forsch 1984 0.90
63 Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease. Eur J Pediatr 1986 0.89
64 Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice. Gene Ther 2006 0.87
65 Structural basis of muscarinic acetylcholine receptor subtype diversity. Trends Pharmacol Sci 1988 0.87
66 Functional diversity of muscarinic receptor subtypes in cellular signal transduction and growth. Trends Pharmacol Sci 1989 0.86
67 Radiation and the Apo2L/TRAIL apoptotic pathway preferentially inhibit the colonization of premalignant human breast cells overexpressing cyclin D1. Cancer Res 2000 0.85
68 Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2. J Immunol 1999 0.85
69 Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody. J Immunol 1994 0.85
70 Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin. Blood 1994 0.85
71 Electrosleep therapy in bronchial asthma. Int Arch Allergy Appl Immunol 1969 0.84
72 In vitro cell-mediated immunologic assay for cow's milk allergy. Pediatrics 1980 0.83
73 Toxicity of different wheat gliadins in coeliac disease. Z Lebensm Unters Forsch 1982 0.83
74 Control of apoptosis signaling by Apo2 ligand. Recent Prog Horm Res 1999 0.82
75 Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody. J Infect Dis 1994 0.82
76 Inhibition of interferon-gamma by an interferon-gamma receptor immunoadhesin. Immunology 1993 0.81
77 Coeliac disease in the Rehovot-Ashdod region of Israel: incidence and ethnic distribution. J Epidemiol Community Health 1984 0.81
78 A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells. J Immunol 1994 0.81
79 CD4 immunoadhesins in anti-HIV therapy: new developments. Int J Cancer Suppl 1992 0.81
80 The value of urinary beta-glucuronidase activity in the assessment of urinary tract infections. Isr J Med Sci 1969 0.81
81 Mumps-associated acute cerebellar ataxia. Am J Dis Child 1992 0.80
82 Generation of soluble interleukin-1 receptor from an immunoadhesin by specific cleavage. Mol Immunol 1994 0.80
83 The third intracellular loop of the 5-hydroxytryptamine2A receptor determines effector coupling specificity. J Neurochem 1995 0.80
84 Molecular and biological properties of an interleukin-1 receptor immunoadhesin. Mol Immunol 1994 0.80
85 Familial infantile renal tubular acidosis and congenital nerve deafness: an autosomal recessive syndrome. Clin Genet 1973 0.80
86 Highly sensitive amperometric immunosensor for the detection of Escherichia coli. Biosens Bioelectron 2009 0.79
87 Systemic lupus erythematosus associated with acute Epstein-Barr virus infection. Am J Kidney Dis 1998 0.79
88 Binding sites of human growth hormone and ovine and bovine prolactins in the mammary gland and the liver of lactating dairy cow. Mol Cell Endocrinol 1984 0.79
89 A muscle disorder as presenting symptom in a child with mucolipidosis IV. Neuropediatrics 1983 0.79
90 Gluten and autism. Lancet 1980 0.79
91 Periodic autonomic dysfunction without pain in a patient with cluster headache. Cephalalgia 2004 0.79
92 Isolation of coeliac active peptide fractions from gliadin. Z Lebensm Unters Forsch 1983 0.78
93 Immune deficiency of T system with possible T cell regulatory activity defect. Isr J Med Sci 1977 0.78
94 Immunologic reaction of psychotic patients to fractions of gluten. Am J Psychiatry 1979 0.78
95 Characterization of lactogen receptors in lactogenic hormone-dependent and independent NB2 lymphoma cell lines. FEBS Lett 1987 0.78
96 Occipital nerve block rapidly eliminates allodynia far from the site of headache: a case report. Cephalalgia 2004 0.78
97 Partial purification and characterization of bovine mammary gland prolactin receptor. Mol Cell Endocrinol 1987 0.78
98 Serum ferritin levels in celiac disease. Am J Clin Pathol 1982 0.77
99 Benign abducens nerve palsy of childhood. Pediatr Neurol 1994 0.77
100 Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG). Biochim Biophys Acta 1994 0.77
101 Fatal pericardial tamponade complicating total parenteral nutrition via a silastic central vein catheter. J Pediatr Gastroenterol Nutr 1988 0.76
102 The structural and functional interrelationships of muscarinic acetylcholine receptor subtypes. Bioessays 1989 0.76
103 Associations between alleles of the major histocompatibility complex-encoded ABC transporter gene TAP2, HLA class II alleles, and celiac disease susceptibility. Hum Immunol 1994 0.76
104 Tight junctions of jejunal surface and crypt cells in celiac disease: a freeze-fracture study. J Pediatr Gastroenterol Nutr 1987 0.76
105 Modification of CD4 immunoadhesin with monomethoxypoly(ethylene glycol) aldehyde via reductive alkylation. Bioconjug Chem 1994 0.76
106 Fixed drug eruption of the scrotum due to methylphenidate. Ann Pharmacother 1992 0.76
107 Familial segregation of cervical ribs, Sprengel anomaly, preaxial polydactyly, anal atresia, and urethral obstruction: a new syndrome? Am J Med Genet 1993 0.76
108 Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent. J Biol Chem 1992 0.76
109 Inhibition of the proliferation of Nb2 cells by femtomolar concentrations of cholera toxin and partial reversal of the effect by 12-O-tetradecanoyl-phorbol-13-acetate. J Cell Biochem 1988 0.75
110 [Risk of HIV infection among health care workers]. Harefuah 1993 0.75
111 Action of 5-iodo-2-deoxyuridine (IUDR) on in vitro transformation of hamster kidney cells by SV-40 virus. Isr J Med Sci 1965 0.75
112 Structural and functional diversity of muscarinic acetylcholine receptor subtypes. Prog Clin Biol Res 1989 0.75
113 Alkaline phosphatase activity in fresh intestinal mucosa and cultured mucosal explants. J Pediatr Gastroenterol Nutr 1984 0.75
114 [Oculo-cerebro-renal syndrome in a newborn]. Harefuah 1985 0.75
115 Occurrence of celiac disease in children in a defined area of Israel. Isr J Med Sci 1983 0.75
116 Cellular immunity in children with coeliac disease. Eur J Pediatr 1982 0.75
117 Comparative study of in vitro and in vivo modulation of lactogenic and somatotropic receptors by native human growth hormone and its modified analog prepared by recombinant deoxyribonucleic acid technology. Endocrinology 1987 0.75
118 Ocular inflammation as an initial manifestation of cutaneous polyarteritis nodosa. Br J Dermatol 1994 0.75
119 Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH. Endocrinology 1986 0.75
120 Combining enhanced metabolic labeling with immunoblotting to detect interactions of endogenous cellular proteins. Biotechniques 2000 0.75
121 [Celiac disease where to? An update]. Harefuah 1990 0.75
122 Changes in body composition, resting energy expenditure, and thermic effect of food in short children on growth hormone therapy. Metabolism 1994 0.75
123 [Prevention of tumor growth by immunization of hamsters with x-irradiated SV40-transformed cells]. Harefuah 1969 0.75
124 The Philadelphia chromosome in two children with chronic myeloid leukemia. Isr J Med Sci 1989 0.75
125 The LIF test. Acta Paediatr 1993 0.75
126 Proceedings: Infantile partial thymic deficiency: correction of some in vitro T functions by thymus humoral factor. Isr J Med Sci 1975 0.75
127 [Paraneoplastic autoimmune syndromes of the nervous system]. Harefuah 1999 0.75
128 Effect of gluten-free diet on an immunological assay for coeliac disease. Lancet 1981 0.75
129 Frequency of HLA-B8 in Israeli children with celiac disease. Isr J Med Sci 1979 0.75
130 [Penicillin VK absorption during fasting and after eating]. Harefuah 1989 0.75
131 A comparative study of lactogenic hormone binding sites in the adrenal gland, ovary and kidney of the lactating cow. J Recept Res 1987 0.75
132 Mitochondrial myopathy with atypical subacute presentation. J Neurol Neurosurg Psychiatry 1998 0.75
133 Immunological assays for coeliac disease. Lancet 1981 0.75
134 Effect of phytohemagglutinin on ascites tumor and SV40 induced sarcoma of hamsters. Isr J Med Sci 1968 0.75
135 Solubilization and characterization of lactogenic hormone receptor from kidney of lactating cow. Mol Cell Endocrinol 1989 0.75
136 Myocarditis and acute infantile hemiparesis. Case report. Helv Paediatr Acta 1984 0.75
137 An apparently immunoregulatory effect of human leukocyte interferon on the blastogenic response in Down's syndrome. Isr J Med Sci 1979 0.75
138 A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells. J Hematother 1995 0.75
139 Immunoglobulin levels in children with celiac disease: variations with age and diet. Isr J Med Sci 1980 0.75